Skip to content
healthcare.dev

TADALAFIL

NDC 70518-4605, TADALAFIL, tablet, from REMEDYREPACK INC..

Product NDC
70518-4605
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211839
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-4605 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TADALAFIL5 mg/1

Pharmacologic classes

Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]

Package NDCNDC-11Package
70518-4605-07051846050050 POUCH in 1 BOX (70518-4605-0) / 1 TABLET in 1 POUCH (70518-4605-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/82dfea4c-9fe5-438a-917f-8f7d395ee8ca

Use it

Look up 70518-4605 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-4605 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-4605. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.